A new family with spastic paraplegia type 51 and novel mutations in AP4E1

• Published in: BMC medical genomics 2021-05, Vol.14 (1), p.131-6, Article 131
• Main Authors: Winkler, Izabela, Miotła, Paweł, Lejman, Monika, Pietrzyk, Aleksandra, Kacprzak, Magdalena, Kubiak, Marcin, Sobczyńska-Tomaszewska, Agnieszka, Skrzypczak, Maciej, Jaszczuk, Ilona
• Format: Article
• Language: English
• Subjects: Adaptor Protein Complex 4 - genetics; AP4E1; Case studies; Cerebral palsy; Child; Chromosome 15; Congenital diseases; Corpus callosum; Deoxyribonucleic acid; Diagnosis; DNA; DNA sequencing; Families & family life; Female; Gene mutations; Genetic aspects; Genetic disorders; Humans; Hybridization; Hypoplasia; Intellectual disabilities; Intellectual Disability - genetics; Magnetic resonance imaging; Male; Microcephaly; Movement disorders; Mutation; Neonates; Neurological disorders; Next-generation sequencing; Paralysis; Paralysis, Spastic; Parents & parenting; Patients; Pediatric research; Pediatrics; Pedigree; Phenotype; Phenotypes; Point mutation; Proteins; Psychomotor retardation; Siblings; Spastic paraplegia; Spastic Paraplegia, Hereditary - genetics; Spasticity
• ISSN: 1755-8794; 1755-8794
• DOI: 10.1186/s12920-021-00980-5

Autosomal recessive mutations in the AP-4 (adaptor protein complex 4) complex subunit ϵ - 1 (AP-4E1) gene on chromosome 15q21.2 are known to cause spastic paraplegia 51 (SPG51). The exact phenotype of SPG51 remains poorly characterized, because only a few families have been reported as carriers of the mutation. In addition, a previous study identified an autosomal dominant mutation in the AP4E1 gene as being associated with persistent stuttering. The aim of the current study was to characterize the phenotype of a paediatric patient with an identified novel AP4E1 mutation presenting with significant psychomotor retardation, intellectual disability and paraplegia. Magnetic resonance imaging was used to identify hypoplasia of the corpus callosum. The DNA sample was tested using multiplex ligation-dependent probe amplification (MLPA) and array comparative genomic hybridization (aCGH). In addition, next-generation sequencing (NGS) was performed using the patient's DNA, and Sanger sequencing was performed using that of his family members. The phenotype was identified to be associated with a novel pathogenic variant c.942_943 + 3delinsCC in the AP4E1 gene. The patient manifested severely delayed psychomotor development, impaired global physical development and general illness. Movement disorders were evident during the neonatal period. The present study identifies a previously unknown disease-inducing AP4E1 gene mutation.